Coherus Completes Surface Oncology Acquisition
September 08, 2023 09:05 ET
|
Coherus BioSciences, Inc.
– Clinical-stage product candidates, casdozokitug and CHS-114, significantly advancenext-generation immuno-oncology portfolio focused on the tumor microenvironment – – I-O combinations will...
Moore Kuehn Encourages AMED, DBTX, RETA, and SURF Investors to Contact Law Firm
August 29, 2023 11:47 ET
|
Moore Kuehn
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Moore Kuehn Encourages PACW, NEWR, CFMS, and SURF Investors to Contact Law Firm
August 01, 2023 11:19 ET
|
Moore Kuehn
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Moore Kuehn Encourages NETI, SURF, KDNY, and NEX Investors to Contact Law Firm
June 16, 2023 13:18 ET
|
Moore Kuehn
NEW YORK, June 16, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Coherus to Acquire Surface Oncology
June 16, 2023 07:01 ET
|
Coherus BioSciences, Inc.
– Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiple next-generation immunotherapies in clinical development funded by growing revenues – ...
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
January 09, 2023 08:00 ET
|
Vaccinex, Inc.
ROCHESTER, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 28, 2019 10:45 ET
|
Schall Law
LOS ANGELES, Aug. 28, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface...
Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Sunnova Energy on Behalf of Stockholders and Encourages Investors to Contact the Firm
August 27, 2019 08:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Casa Systems, Inc. (NASDAQ: CASA), Greenlane Holdings, Inc. (NASDAQ: GNLN),...
Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm
August 14, 2019 20:55 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Casa Systems, Inc. (NASDAQ: CASA), Greenlane Holdings, Inc. (NASDAQ: GNLN),...
Bragar Eagel & Squire, P.C. is Investigating Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm
August 07, 2019 21:30 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Greenlane Holdings, Inc. (NASDAQ: GNLN), Surface Oncology, Inc. (NASDAQ: SURF),...